Obeseity In Us
-
{
- All
- News
-
Higher-Dose Wegovy Gets US Nod, Trials Show Over 20% Average Weight Loss, Says Drugmaker
Novo Nordisk said it plans to launch the new formulation, (semaglutide 7.2 mg), in the United States in April 2026.
-
Cheap Generic Ozempic To Hit India: Patent Exit Sparks Weight-Loss Drug Boom
Swati Pradhan sees about 12 obesity patients a day at her clinic in southern Mumbai. She expects this number to at least double from this month as Indian drug makers prepare to launch off-patent versions of Novo Nordisk A/S's blockbuster weight.
-
RFK Jr Questions Safety Of Sugary Coffee Drinks Sold By Starbucks And Dunkin'
"We're gonna ask Dunkin' Doughnuts and Starbucks, show us the safety data that shows that it's OK for a teenage girl to drink an iced coffee with 115 grams of sugar in it. I don't think they're gonna be able to do it," said Robert F. Kennedy Jr.
-
Novo Nordisk Sues Telehealth Company Over 'Knock-Off' Weight Loss Drugs, Flags Patient Safety Risks
The lawsuit, filed in the US, alleges that Hims infringed Novo Nordisk's patent by mass marketing compounded semaglutide products that have not been cleared by the US Food and Drug Administration (FDA).
-
Ozempic Maker's Weight Loss Pill Gets Key Clearance In US, Launch Days Away
The US FDA has approved Wegovy pill, the first oral GLP-1 drug for weight loss. With Ozempic already in India, experts say this signals a major shift in obesity care, raising hopes, questions on access, cost and regulation for Indians.
-
San Francisco Sues Oreo, Coca-Cola, KitKat In First-Ever Lawsuit Over Ultra-Processed Foods
The lawsuit links the rise of ultra-processed foods to increasing rates of obesity, diabetes and cancer.
-
US Teen Starved, Locked Away By Obese Family In Shocking Abuse Case: "Skin And Bones At 16 kg"
The girl was allegedly confined to a locked room with no mattress, forced to sleep on the bare floor, and denied access to regular food, water, and bathroom use.
-
US Adds New Grounds To Deny Visas: Obesity, Diabetes, Heart Disease
Foreign nationals applying for a visa to live in the US might be rejected if they have health conditions such as diabetes or obesity, according to a government directive issued by the Trump administration on Thursday.
-
WHO Backs Weight-Loss Drugs To Treat Diabetes, Obesity, Urges Cheap Generics
The World Health Organization recommended a range of blockbuster weight-loss drugs to treat diabetes and obesity globally for the first time on Friday, calling for cheap generic versions to be made available for people in developing countries.
-
Obesity, Chronic Illnesses, And Mental Health: Study Says US Children Are Sicker Than Ever
A recent study reveals a concerning trend in US children's health, with worsening physical and mental health outcomes over the past 17 years, including increased obesity, chronic diseases, and mental health issues.
-
Higher-Dose Wegovy Gets US Nod, Trials Show Over 20% Average Weight Loss, Says Drugmaker
Novo Nordisk said it plans to launch the new formulation, (semaglutide 7.2 mg), in the United States in April 2026.
-
Cheap Generic Ozempic To Hit India: Patent Exit Sparks Weight-Loss Drug Boom
Swati Pradhan sees about 12 obesity patients a day at her clinic in southern Mumbai. She expects this number to at least double from this month as Indian drug makers prepare to launch off-patent versions of Novo Nordisk A/S's blockbuster weight.
-
RFK Jr Questions Safety Of Sugary Coffee Drinks Sold By Starbucks And Dunkin'
"We're gonna ask Dunkin' Doughnuts and Starbucks, show us the safety data that shows that it's OK for a teenage girl to drink an iced coffee with 115 grams of sugar in it. I don't think they're gonna be able to do it," said Robert F. Kennedy Jr.
-
Novo Nordisk Sues Telehealth Company Over 'Knock-Off' Weight Loss Drugs, Flags Patient Safety Risks
The lawsuit, filed in the US, alleges that Hims infringed Novo Nordisk's patent by mass marketing compounded semaglutide products that have not been cleared by the US Food and Drug Administration (FDA).
-
Ozempic Maker's Weight Loss Pill Gets Key Clearance In US, Launch Days Away
The US FDA has approved Wegovy pill, the first oral GLP-1 drug for weight loss. With Ozempic already in India, experts say this signals a major shift in obesity care, raising hopes, questions on access, cost and regulation for Indians.
-
San Francisco Sues Oreo, Coca-Cola, KitKat In First-Ever Lawsuit Over Ultra-Processed Foods
The lawsuit links the rise of ultra-processed foods to increasing rates of obesity, diabetes and cancer.
-
US Teen Starved, Locked Away By Obese Family In Shocking Abuse Case: "Skin And Bones At 16 kg"
The girl was allegedly confined to a locked room with no mattress, forced to sleep on the bare floor, and denied access to regular food, water, and bathroom use.
-
US Adds New Grounds To Deny Visas: Obesity, Diabetes, Heart Disease
Foreign nationals applying for a visa to live in the US might be rejected if they have health conditions such as diabetes or obesity, according to a government directive issued by the Trump administration on Thursday.
-
WHO Backs Weight-Loss Drugs To Treat Diabetes, Obesity, Urges Cheap Generics
The World Health Organization recommended a range of blockbuster weight-loss drugs to treat diabetes and obesity globally for the first time on Friday, calling for cheap generic versions to be made available for people in developing countries.
-
Obesity, Chronic Illnesses, And Mental Health: Study Says US Children Are Sicker Than Ever
A recent study reveals a concerning trend in US children's health, with worsening physical and mental health outcomes over the past 17 years, including increased obesity, chronic diseases, and mental health issues.
